A new omics technology-cancer antigenomics

Yang Jun,Liu Ni,Li Zongfang

DOI: https://doi.org/10.3969/j.issn.1672-4992.2013.06.65

2013-01-01

Journal of Modern Oncology

Abstract:Screening tumor-associated antigens(TAA) is the foundation and bottleneck for early diagnosis and biotherapy of tumor.By using the existing technology(SEREX,SERPA,protein chip,etc.),a series of important achievements have been obtained in screening TAA.But now,the existing technology can not meet the needs of effective screening TAA.Therefore,establishing a new screening strategy and technology platform become one of important challenges in TAA screening.Recently,a new omics technology-antigenome has been set up for rapidly screening all antigens of pathogens,by using it,a variety antigenome of bacteria has been determined.In this paper,based on the research results of the immunomics,cancer immunomics,Antigenome,epitomics and other omes and-omics,we attempt to establish a new concept of Cancer antigenome(Tumor antigenome)and Cancer antigenomics(Tumor antigenomics).They give the definition of Cancer antigenome refers to the total of the antigen within the tumor cells(protein antigen or nonprotein antigen);they give the definition of Cancer antigenomics refers to screen and detect the cancer antigenome of a tumor by using immunology,mass spectrometry technology.In order to remarkably raise the efficiency and specificity of antigenome screening.This technology will regard immunology screening candidate antigens as the most important condition for TAA screening.The technical scheme of Cancer antigenomics is by using xenoimmune vaccine immune consist of all of tumor tissue lysate as immunogen to immune animals for preparating specific antibody,secondly by using the immune separation technology(such as immune affinity chromatography,immune precipitation technology,mass spectrum technology,etc.) to separate and identify TAA in tumor tissue lysate.Obviously,Cancer antigenomics provides a new technology method for screening TAA.It will play very important role in screening and identification biological target for early diagnosis and biotherapy of tumor.